Clearside Biomedical Net Income
| CLSDDelisted Stock | USD 0.41 0.16 28.07% |
As of the 26th of February, Clearside Biomedical shows the mean deviation of 6.75, and Risk Adjusted Performance of (0.20). Clearside Biomedical technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Clearside Biomedical market risk adjusted performance, variance, as well as the relationship between the Variance and value at risk to decide if Clearside Biomedical is priced correctly, providing market reflects its regular price of 0.41 per share. As Clearside Biomedical is a penny stock we also strongly suggest to validate its jensen alpha numbers.
Clearside Biomedical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Clearside Biomedical's valuation are provided below:Clearside Biomedical does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Clearside |
Search Suggestions
| CL | Colgate Palmolive | Company |
| CLDT-PA | Chatham Lodging Trust | Company |
| CLM | Cornerstone Strategic Value | Fund |
| CLY | Blackrock | ETF |
| CLOAK | CLOAK | Cryptocurrency |
| CLUSD | Crude Oil | Commodity |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Clearside Biomedical reported net income of (34.35 Million). This is 110.07% lower than that of the Pharmaceuticals sector and 149.04% lower than that of the Health Care industry. The net income for all United States stocks is 106.02% higher than that of the company.
Clearside Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Clearside Biomedical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Clearside Biomedical could also be used in its relative valuation, which is a method of valuing Clearside Biomedical by comparing valuation metrics of similar companies.Clearside Biomedical is currently under evaluation in net income category among its peers.
Clearside Fundamentals
| Return On Equity | -13.1 | |||
| Return On Asset | -0.7 | |||
| Operating Margin | (35.02) % | |||
| Current Valuation | (2.33 M) | |||
| Shares Outstanding | 5.23 M | |||
| Shares Owned By Insiders | 12.88 % | |||
| Shares Owned By Institutions | 13.67 % | |||
| Number Of Shares Shorted | 141.01 K | |||
| Price To Earning | 130.00 X | |||
| Price To Book | 3.93 X | |||
| Price To Sales | 0.64 X | |||
| Revenue | 1.66 M | |||
| Gross Profit | 2.93 M | |||
| EBITDA | (24.35 M) | |||
| Net Income | (34.35 M) | |||
| Cash And Equivalents | 29.03 M | |||
| Cash Per Share | 0.48 X | |||
| Total Debt | 52.47 M | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 5.56 X | |||
| Book Value Per Share | (10.31) X | |||
| Cash Flow From Operations | (24.7 M) | |||
| Short Ratio | 3.86 X | |||
| Earnings Per Share | (5.11) X | |||
| Target Price | 60.0 | |||
| Number Of Employees | 32 | |||
| Beta | 1.79 | |||
| Market Capitalization | 2.15 M | |||
| Total Asset | 25.13 M | |||
| Retained Earnings | (355.27 M) | |||
| Working Capital | 16.48 M | |||
| Current Asset | 20.48 M | |||
| Current Liabilities | 5.2 M | |||
| Net Asset | 25.13 M |
About Clearside Biomedical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Clearside Biomedical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Clearside Biomedical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Clearside Biomedical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Consideration for investing in Clearside Stock
If you are still planning to invest in Clearside Biomedical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Clearside Biomedical's history and understand the potential risks before investing.
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Commodity Directory Find actively traded commodities issued by global exchanges |